Perakizumab

Perakizumab
[[File:|frameless|220px|alt=|]]
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number	89957-37-9
PubChem
DrugBank
ChemSpider	none
KEGG

Perakizumab (INN) is a humanized monoclonal antibody designed for the treatment of arthritis.<ref>Statement On A Nonproprietary Name Adopted By The USAN Council - Perakizumab, American Medical Association.</ref> It binds to IL17A and acts as an immunomodulator.<ref>World Health Organization,

 International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 107, 
 WHO Drug Information, 
 2012,
 Vol. 26(Issue: 2),
 
 
 
 
 
 Full text,</ref>

This drug was developed by Genentech/Roche.

References

<references/>

   This article is a monoclonal antibody–related stub. You can help WikiMD by expanding it!

   This article is a medical stub. You can help WikiMD by expanding it!